Polaryx Therapeutics, Inc. Common Stock

PLYX

Healthcare|Biotechnology|US

$1.80

+0.06 (+3.45%)

DCF Value

$0.10

Tangible Book / Share

$0.23

Cash / Share

$0.24

Clinical Trials (0)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug